Table 3.
Mean differences in health-related quality of life (SF-36) in the two study groups at the end of the study (3 months) as compared with baseline
| Study group | PCS score (3 months versus baseline)
|
MCS score (3 months versus baseline)
|
||||
|---|---|---|---|---|---|---|
| Mean (SD) | 95% CI | P-value | Mean (SD) | 95% CI | P-value | |
| A, n=31* | −1.70 (4.69) | −3.42 to 0.02 | 0.052 | −1.41 (5.46) | −3.41 to 0.60 | 0.161 |
| B, n=30† | 7.14 (5.81) | 4.97–9.31 | 0.000 | 5.96 (7.64) | 3.10–8.81 | 0.0002 |
Notes:
*
Group A patients treated with placebo (controls).
†
Group B patients treated with dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants (Brudysec® 1.5 g, Brudy Laboratories, Barcelona, Spain).
Abbreviations: PCS, Physical Component Summary; MCS, Mental Component Summary; CI, confidence interval; SF-36, 36-Item Short Form Health Survey; SD, standard deviation.